These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23021333)

  • 41. Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans.
    Itokawa M; Arai M; Kato S; Ogata Y; Furukawa A; Haga S; Ujike H; Sora I; Ikeda K; Yoshikawa T
    Neurosci Lett; 2003 Aug; 347(3):202-4. PubMed ID: 12875921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic modulation of plasma NPY stress response is suppressed in substance abuse: association with clinical outcomes.
    Xu K; Hong KA; Zhou Z; Hauger RL; Goldman D; Sinha R
    Psychoneuroendocrinology; 2012 Apr; 37(4):554-64. PubMed ID: 21917383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropeptide Y gene-by-psychosocial stress interaction effect is associated with obesity in a Korean population.
    Kim HJ; Min KB; Min JY
    Psychoneuroendocrinology; 2016 Jul; 69():10-5. PubMed ID: 27010740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic variation in human NPY expression affects stress response and emotion.
    Zhou Z; Zhu G; Hariri AR; Enoch MA; Scott D; Sinha R; Virkkunen M; Mash DC; Lipsky RH; Hu XZ; Hodgkinson CA; Xu K; Buzas B; Yuan Q; Shen PH; Ferrell RE; Manuck SB; Brown SM; Hauger RL; Stohler CS; Zubieta JK; Goldman D
    Nature; 2008 Apr; 452(7190):997-1001. PubMed ID: 18385673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conserved regulatory motifs at phenylethanolamine N-methyltransferase (PNMT) are disrupted by common functional genetic variation: an integrated computational/experimental approach.
    Rodríguez-Flores JL; Zhang K; Kang SW; Wen G; Ghosh S; Friese RS; Mahata SK; Subramaniam S; Hamilton BA; O'Connor DT
    Mamm Genome; 2010 Apr; 21(3-4):195-204. PubMed ID: 20204374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional characterisation of the bovine neuropeptide Y gene promoter and evaluation of the transcriptional activities of promoter haplotypes.
    Alam T; Bahar B; Waters SM; McGee M; O'Doherty JV; Sweeney T
    Mol Biol Rep; 2012 Feb; 39(2):919-28. PubMed ID: 21562764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association study of two functional single nucleotide polymorphisms of neuropeptide y gene with multiple sclerosis.
    Mohammadi SM; Shirvani Farsani Z; Dosti R; Sahraian MA; Behmanesh M
    Neuropeptides; 2016 Dec; 60():45-50. PubMed ID: 27559040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk.
    Zhang L; Rao F; Zhang K; Khandrika S; Das M; Vaingankar SM; Bao X; Rana BK; Smith DW; Wessel J; Salem RM; Rodriguez-Flores JL; Mahata SK; Schork NJ; Ziegler MG; O'Connor DT
    J Clin Invest; 2007 Sep; 117(9):2658-71. PubMed ID: 17717598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of clonidine on plasma catecholamines and neuropeptide Y in hypertensive patients at rest and during stress.
    Puybasset L; Lacolley P; Laurent S; Mignon F; Billaud E; Cuche JL; Comoy E; Safar M
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):912-9. PubMed ID: 7687716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressure.
    O'Connor DT; Zhu G; Rao F; Taupenot L; Fung MM; Das M; Mahata SK; Mahata M; Wang L; Zhang K; Greenwood TA; Shih PA; Cockburn MG; Ziegler MG; Stridsberg M; Martin NG; Whitfield JB
    Circulation; 2008 Jul; 118(3):247-57. PubMed ID: 18591442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropeptide Y gene functional polymorphism influences susceptibility to hypertension in Indian population.
    Bhaskar LV; Thangaraj K; Non AL; Praveen Kumar K; Pardhasaradhi G; Singh L; Rao VR
    J Hum Hypertens; 2010 Sep; 24(9):617-22. PubMed ID: 20033074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.
    Kloster E; Saft C; Akkad DA; Epplen JT; Arning L
    J Mol Med (Berl); 2014 Feb; 92(2):177-84. PubMed ID: 24121255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity.
    Seasholtz TM; Wessel J; Rao F; Rana BK; Khandrika S; Kennedy BP; Lillie EO; Ziegler MG; Smith DW; Schork NJ; Brown JH; O'Connor DT
    Hypertension; 2006 May; 47(5):937-47. PubMed ID: 16585408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular characterization of neuropeptide Y gene in Chinese perch, an acanthomorph fish.
    Liang XF; Li GZ; Yao W; Cheong LW; Liao WQ
    Comp Biochem Physiol B Biochem Mol Biol; 2007 Sep; 148(1):55-64. PubMed ID: 17537656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release.
    Takiyyuddin MA; Brown MR; Dinh TQ; Cervenka JH; Braun SD; Parmer RJ; Kennedy B; O'Connor DT
    J Auton Pharmacol; 1994 Jun; 14(3):187-200. PubMed ID: 7929473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
    Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.
    Rao F; Wen G; Gayen JR; Das M; Vaingankar SM; Rana BK; Mahata M; Kennedy BP; Salem RM; Stridsberg M; Abel K; Smith DW; Eskin E; Schork NJ; Hamilton BA; Ziegler MG; Mahata SK; O'Connor DT
    Circulation; 2007 May; 115(17):2271-81. PubMed ID: 17438154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects--the cardiovascular risk in young Finns study.
    Jaakkola U; Kakko T; Juonala M; Lehtimäki T; Viikari J; Jääskeläinen AE; Mononen N; Kähönen M; Koskinen T; Keltikangas-Järvinen L; Raitakari O; Kallio J
    Neuropeptides; 2012 Dec; 46(6):321-8. PubMed ID: 23122776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Hypertension Risk Variant Rs820430 Functions as an Enhancer of SLC4A7.
    Wang L; Li H; Yang B; Guo L; Han X; Li L; Li M; Huang J; Gu D
    Am J Hypertens; 2017 Feb; 30(2):202-208. PubMed ID: 27784683
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional regulation of neuronal genes and its effect on neural functions: transcriptional regulation of neuropeptide Y gene by leptin and its effect on feeding.
    Higuchi H; Hasegawa A; Yamaguchi T
    J Pharmacol Sci; 2005 Jul; 98(3):225-31. PubMed ID: 16006740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.